ICON is Collaborating with Practice Fusion, Inc. to Advance Health Research
The collaboration between ICON and Practice Fusion emphasizes innovative uses of data collected directly through the Practice Fusion platform to facilitate health research
ICON and DIA driving Insights to Action with DIA Live 2018
Social media aggregation site will highlight real-time digital conversations at DIA 2018
ICON enhances Endpoint Adjudication Services
Agreement to use Judi, a comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality
ICON Launches FIRECREST Financial Disclosure
The solution enables secure, centralised, electronic distribution and response capture of Financial Disclosure information.
ICON named by Forbes as one of the best employers in America
Forbes ranking of top employers drawn from a survey of 30,000 US employees in 25 industry sectors
ICON Announces Clinical Research partnership with DuPage Medical Group
Additional PMG Research site locations enhances ICON’s site and patient engagement capabilities
ICON sponsors industry-wide clinical trials survey to support Transforming Trials initiative
A new survey of pharmaceutical executives and professionals by ICON and Pharma Intelligence, which examines the key challenge of declining research and development (R&D) efficiency.
ICON Reports First Quarter 2018 Results
Q1 2018 Financial Results
ICON and AMAG Pharmaceuticals Honoured as Clinical Research Team of the Year
The award honoured the achievements of the team for executing a Phase III iron deficiency anaemia trial
ICON Receives 2018 CRO Phase IV Leadership Award
ICON recognised for specialised real world evidence and late phase services.